Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Hox-A5 (HOXA5) is a sequence-specific transcription factor belonging to the homeobox gene family, which encodes proteins that control positional identity during embryonic development. HOXA5 is part of the HOX gene cluster A on human chromosome 7 and binds specific DNA motifs to regulate gene expression essential for morphogenesis, cell differentiation, and regional specification along the body axis. Dysregulation of HOXA5, often through methylation-mediated silencing, is implicated in various malignancies—including breast, lung, colon cancers, and leukemias—largely due to its functions in upregulating tumor suppressor proteins (like p53), inhibiting angiogenesis, and modulating Wnt and p53 pathways. Loss of HOXA5 contributes to increased cell proliferation, reduced apoptosis, and enhanced tumor progression, making its pathway a focus for epigenetic therapies, especially in acute myeloid leukemia and solid tumors
Reactivation of silenced HOXA5 via DNA hypomethylation (as by decitabine) may restore its tumor-suppressive functions, including upregulation of p53 and block of angiogenesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Hox-A5 (HOXA5).